252 related articles for article (PubMed ID: 33826022)
1. Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya: A Qualitative Study of Client and Provider Perspectives.
Roche SD; Wairimu N; Mogere P; Kamolloh K; Odoyo J; Kwena ZA; Bukusi EA; Ngure K; Baeten JM; Ortblad KF
AIDS Behav; 2021 Dec; 25(12):3871-3882. PubMed ID: 33826022
[TBL] [Abstract][Full Text] [Related]
2. Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation.
Ortblad KF; Mogere P; Roche S; Kamolloh K; Odoyo J; Irungu E; Mugo NR; Pintye J; Baeten JM; Bukusi E; Ngure K;
BMC Health Serv Res; 2020 Nov; 20(1):1034. PubMed ID: 33176785
[TBL] [Abstract][Full Text] [Related]
3. Stand-alone model for delivery of oral HIV pre-exposure prophylaxis in Kenya: a single-arm, prospective pilot evaluation.
Ortblad KF; Mogere P; Omollo V; Kuo AP; Asewe M; Gakuo S; Roche S; Mugambi M; Mugambi ML; Stergachis A; Odoyo J; Bukusi EA; Ngure K; Baeten JM
J Int AIDS Soc; 2023 Jun; 26(6):e26131. PubMed ID: 37306128
[TBL] [Abstract][Full Text] [Related]
4. Low selection of HIV PrEP refills at private pharmacies among clients who initiated PrEP at public clinics: findings from a mixed-methods study in Kenya.
Ortblad KF; Kuo AP; Mogere P; Roche SD; Kiptinness C; Wairimu N; Gakuo S; Baeten JM; Ngure K
BMC Health Serv Res; 2024 May; 24(1):618. PubMed ID: 38730398
[TBL] [Abstract][Full Text] [Related]
5. The Fidelity of a Pharmacy-Based Oral HIV Pre-Exposure Prophylaxis Delivery Model in Kenya.
Omollo V; Asewe M; Mogere P; Maina G; Kuo AP; Odoyo J; Oware K; Baeten JM; Kohler P; Owens T; Bukusi EA; Ngure K; Ortblad KF
J Acquir Immune Defic Syndr; 2023 Aug; 93(5):379-386. PubMed ID: 37079900
[TBL] [Abstract][Full Text] [Related]
6. Measuring the performance of HIV self-testing at private pharmacies in Kenya: a cross-sectional study.
Ortblad KF; Kwach B; Zhang S; Asewe M; Ongwen PA; Malen RC; Harkey K; Odoyo J; Gathii P; Rota G; Sharma M; Were DK; Ngure K; Omollo V; Bukusi EA
J Int AIDS Soc; 2023 Oct; 26(10):e26177. PubMed ID: 37848405
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness, feasibility and acceptability of HIV service delivery at private pharmacies in sub-Saharan Africa: a scoping review.
Kuo AP; Roche SD; Mugambi ML; Pintye J; Baeten JM; Bukusi E; Ngure K; Stergachis A; Ortblad KF
J Int AIDS Soc; 2022 Oct; 25(10):e26027. PubMed ID: 36285619
[TBL] [Abstract][Full Text] [Related]
8. Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial.
Lagat HK; Pintye J; Harrington E; Houck S; Kwena Z; Lenn M; Mogaka F; Momanyi V; Mugambi M; Nyerere B; Odoyo J; Omollo V; Ortblad KF; Rota G; Sharma M; Bukusi EA
Trials; 2024 Jun; 25(1):394. PubMed ID: 38890744
[TBL] [Abstract][Full Text] [Related]
9. Getting HIV Pre-exposure Prophylaxis (PrEP) into Private Pharmacies: Global Delivery Models and Research Directions.
Roche SD; Were D; Crawford ND; Tembo A; Pintye J; Bukusi E; Ngure K; Ortblad KF
Curr HIV/AIDS Rep; 2024 Jun; 21(3):116-130. PubMed ID: 38517671
[TBL] [Abstract][Full Text] [Related]
10. PrEP distribution in pharmacies: a systematic review.
Kennedy CE; Yeh PT; Atkins K; Ferguson L; Baggaley R; Narasimhan M
BMJ Open; 2022 Feb; 12(2):e054121. PubMed ID: 35190430
[TBL] [Abstract][Full Text] [Related]
11. Online HIV prophylaxis delivery: Protocol for the ePrEP Kenya pilot study.
Kiptinness C; Naik P; Thuo N; Malen RC; Dettinger JC; Pintye J; Rafferty M; Jomo E; Nyamasyo N; Wood T; Isabelli P; Morris S; Hattery D; Stergachis A; Were D; Sharma M; Ngure K; Mugambi ML; Ortblad KF
Front Public Health; 2023; 11():1054559. PubMed ID: 36908449
[TBL] [Abstract][Full Text] [Related]
12.
Vera M; Bukusi E; Achieng P; Aketch H; Araka E; Baeten JM; Beima-Sofie K; John-Stewart G; Kohler PK; Mugambi ML; Nyerere B; Odoyo J; Omom C; Omondi C; Ortblad KF; Pintye J
J Int Assoc Provid AIDS Care; 2023; 22():23259582231215882. PubMed ID: 37997351
[TBL] [Abstract][Full Text] [Related]
13. Provider perspectives on service delivery modifications to maintain access to HIV pre-exposure prophylaxis during the COVID-19 pandemic: qualitative results from a PrEP implementation project in Kenya.
Velloza J; Roche SD; Owidi EJ; Irungu EM; Dollah A; Kwach B; Thuo NB; Morton JF; Mugo N; Bukusi EA; O'Malley G; Ngure K; Baeten JM; Mugwanya KK;
J Int AIDS Soc; 2023 Feb; 26(2):e26055. PubMed ID: 36739603
[TBL] [Abstract][Full Text] [Related]
14. Implementation strategies for integrating pre-exposure prophylaxis for HIV prevention and family planning services for adolescent girls and young women in Kenya: a qualitative study.
Roche SD; Barnabee G; Omollo V; Mogaka F; Odoyo J; Bukusi EA; Morton JF; Johnson R; Celum C; Baeten JM; O'Malley G
BMC Health Serv Res; 2022 Mar; 22(1):422. PubMed ID: 35354456
[TBL] [Abstract][Full Text] [Related]
15. Barriers to and strategies for early implementation of pharmacy-delivered HIV PrEP services in Kenya: An analysis of routine data.
Nakambale HN; Roche SD; Mogere P; Omollo V; Kuo AP; Stergachis A; Baeten JM; Bukusi E; Ngure K; Mugambi ML; Ortblad KF
Front Reprod Health; 2023; 5():1023568. PubMed ID: 36895656
[TBL] [Abstract][Full Text] [Related]
16. Provider-client rapport in pre-exposure prophylaxis delivery: a qualitative analysis of provider and client experiences of an implementation science project in Kenya.
Omollo V; Roche SD; Mogaka F; Odoyo J; Barnabee G; Bukusi EA; Katz AWK; Morton J; Johnson R; Baeten JM; Celum C; O'Malley G
Sex Reprod Health Matters; 2022 Dec; 30(1):2095707. PubMed ID: 36169648
[TBL] [Abstract][Full Text] [Related]
17. A one-stop shop model for improved efficiency of pre-exposure prophylaxis delivery in public clinics in western Kenya: a mixed methods implementation science study.
Roche SD; Odoyo J; Irungu E; Kwach B; Dollah A; Nyerere B; Peacock S; Morton JF; O'Malley G; Bukusi EA; Baeten JM; Mugwanya KK
J Int AIDS Soc; 2021 Dec; 24(12):e25845. PubMed ID: 34898032
[TBL] [Abstract][Full Text] [Related]
18. Assessing preferences for HIV pre-exposure prophylaxis (PrEP) delivery services via online pharmacies in Kenya: protocol for a discrete choice experiment.
Chen Y; Saldarriaga EM; Montano MA; Ngure K; Thuo N; Kiptinness C; Rafferty M; Terris-Prestholt F; Stergachis A; Mugambi ML; Ortblad KF; Sharma M
BMJ Open; 2023 Apr; 13(4):e069195. PubMed ID: 37012008
[TBL] [Abstract][Full Text] [Related]
19. Process evaluation of PrEP implementation in Kenya: adaptation of practices and contextual modifications in public HIV care clinics.
Irungu EM; Odoyo J; Wamoni E; Bukusi EA; Mugo NR; Ngure K; Morton JF; Mugwanya KK; Baeten JM; O'Malley G;
J Int AIDS Soc; 2021 Sep; 24(9):e25799. PubMed ID: 34496148
[TBL] [Abstract][Full Text] [Related]
20. Effect of differentiated direct-to-pharmacy PrEP refill visits supported with client HIV self-testing on clinic visit time and early PrEP continuation.
Zewdie KB; Ngure K; Mwangi M; Mwangi D; Maina S; Etyang L; Maina G; Ogello V; Owidi E; Mugo NR; Baeten JM; Mugwanya KK
J Int AIDS Soc; 2024 Mar; 27(3):e26222. PubMed ID: 38446643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
